FAUCI DIARY ARCHIVE — Friday, November 19, 2004
https://faucisdiary.com/diary/2004-11-19

Text below is verbatim from the released PDFs, with the original line breaks.
==============================================================================

DIARY ENTRY — Friday, November 19, 2004
Source: Diary Prequel, p. 110 of 2026.07.27_Diary-Prequel-.pdf
Words: 164
------------------------------------------------------------------------------
I arranged a meeting among Medimmune (Flumist), the FDA, and
Stewart Simonson to try to pursue ways to get broader approval and utilization of Flumist
for next year to make up for the anticipated shortages since Chiron will almost certainly
not be able to re-fill the gap by next year. Present at the meeting were Medimmune CEO
David Mott, President Jim Young, VP of Reg Affairs Peter Patriarca, CMO Edward
Connor, Sr. Director Scientific Affairs Kathleen Coelingh. From FDA were Les
Crawford (Acting Comm) and Jesse Goodman (head of CBER). Also, Stewart
Simonson, Bruce Gellin, Pamela McInnes, Ralph Tate. I am trying to be the facilitator to
have FDA look at Medimmune data on 50 to 64 year old people sooner rather than later
so that Medimmune can produce an extra 10 million doses for next year. They need
approval for this age group or else then cannot take the risk of making 10 million more
doses and not be able to sell them.